Close
Close

Novel Immunotherapy Strategies

3.0
3.0 from 2 votes
Date: 13 - 14 November, 2017
Location: Lisboa, Portugal

Checkpoint inhibitors and adoptive T therapies are now in the clinic with patients showing improved survival rates and tumor shrinkage. Success depends on understanding the immune landscape which leads investigators to combine different approaches. This conference track features recent advances together with inevitable emerging challenges. It presents enhancement of T cell potency and specificity, means of overcoming off-target toxicity and adverse reactions, and includes a session on overcoming resistance to known immunotherapies.

3.0
3.0 from 2 votes